Effect of Botulinum A toxin versus anticholinergic on clinical symptoms of patients with overactive bladder

Phase 3

• Conditions: Overactive bladder.; Overactive bladder; N32.81

• Registration Number: IRCT20120215009014N488
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

Age 18 to 80 years
Overactive bladder

Exclusion Criteria

Pregnancy or breastfeeding
Neuromuscular diseases
Taking anticoagulants
Allergy to egg white

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of clinical symptoms (frequency, urgency, nocturia). Timepoint: Before the intervention and 3 months later. Method of measurement: Using International Incontinence Consultation Questionnaire (ICIQ).